• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Factors leading to the risk of stroke mortality: a cross-sectional study with lung cancer patient-based large sample
To identify the risk factors for stroke mortality among lung cancer patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) database. The clinical data of lung cancer patients diagnosed between 2004 and 2016 were collected in the SEER database. The stroke mortality of lung cancer patients was compared with the general population using standardized mortality ratios (SMRs). COX proportional hazard model was applied to analyze the risk factors for stroke mortality among lung cancer patients. Among 82 454 patients, 4821 (5.85%) died of stroke. The stroke mortality rate in lung cancer patients signific...
Source: European Journal of Cancer Prevention - December 16, 2021 Category: Cancer & Oncology Tags: Lung cancer Source Type: research

Short ‐term outcomes in patients with lung cancer‐associated acute ischemic stroke
ConclusionIn this study, we have identified three independent risk factors associated with poor short-term outcomes in pLCAIS: higher NC, CRP, and D-dimer levels. These findings may be helpful for clinicians in identifying poor short-term outcomes patients.
Source: Thoracic Cancer - August 18, 2022 Category: Cancer & Oncology Authors: Ruixia Wang, Peijun Xu, Jun Zhou, Yuanyuan Meng, Kun Men, Jinyuan Zhang, Wei Lu, Juanjuan Xue, Xin Li Tags: ORIGINAL ARTICLE Source Type: research

Ischemic stroke in a patient with EGFR ‐mutated non–small‐cell lung cancer after treatment with ramucirumab
This article presents the case of a non–small-cell lun g cancer patient who experienced a new ischemic stroke after treatment with ramucirumab. The findings suggest that further studies may be necessary to investigate the relationship between ramucirumab and the risk of ischemic stroke.
Source: Thoracic Cancer - October 29, 2022 Category: Cancer & Oncology Authors: Guo ‐Yu Chen, Wen‐Chien Cheng, Chih‐Yen Tu Tags: CASE REPORT Source Type: research

The global burden of disease attributable to ambient fine particulate matter in 204 countries and territories, 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019
Ecotoxicol Environ Saf. 2022 May 4;238:113588. doi: 10.1016/j.ecoenv.2022.113588. Online ahead of print.ABSTRACTUnderstanding the spatio-temporal patterns of the disease burden attributable to ambient PM2.5 across the world is essential for the prevention of related diseases, as well as ambient PM2.5 control. Following the framework and methodology of the Global Burden of Disease Study (GBD) in 2019, the global, regional, and national data on ambient PM2.5-attributable death and disability-adjusted life years (DALYs), and the age-standardized rates of mortality (ASMR) and disability-adjusted life years (ASDR) were summariz...
Source: Cancer Control - May 7, 2022 Category: Cancer & Oncology Authors: Shaowei Sang Chong Chu Tongchao Zhang Hui Chen Xiaorong Yang Source Type: research

Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM < sub > 2.5 < /sub > , BC, NO < sub > 2 < /sub > , and O < sub > 3 < /sub > : An Analysis of European Cohorts in the ELAPSE Project
CONCLUSIONS: Long-term exposure to PM2.5, NO2, and BC was positively associated with natural-cause and cause-specific mortality in the pooled cohort and the administrative cohorts. Associations were found well below current limit values and guidelines for PM2.5 and NO2. Associations tended to be supralinear, with steeper slopes at low exposures with no indication of a threshold. Two-pollutant models documented the importance of characterizing the ambient mixture with both NO2 and PM2.5. We mostly found negative associations with O3. In two-pollutant models with NO2, the negative associations with O3 were attenuated to esse...
Source: Cancer Control - September 15, 2022 Category: Cancer & Oncology Authors: Brunekreef Bert Strak Maciej Chen Jie J Andersen Zorana Atkinson Richard Bauwelinck Mariska Bellander Tom Boutron Marie-Christine Brandt J ørgen Carey Iain Cesaroni Giulia Forastiere Francesco Fecht Daniela Gulliver John Hertel Ole Hoffmann Barbara de Ho Source Type: research

Abstract B84: Increasing disparities in breast cancer mortality for young black women in the U.S. from 1979-2010
Conclusions: Though mortality rates have declined over the past 30 years for women under 50, significant disparities in the two leading causes of death, cancer and CVD, remain. The persistence of disparities across diseases highlights the need to focus on improving health outcomes broadly, in addition to disease centered approaches, in order to prevent premature deaths among young women. The breast cancer mortality rate was two times greater among black women younger than 50 compared to white women, indicating a more profound disparity in younger women than older women. Furthermore, while relative disparities have decrease...
Source: Cancer Epidemiology Biomarkers and Prevention - November 13, 2014 Category: Cancer & Oncology Authors: McCarthy, A. M., Yang, J., Armstrong, K. Tags: Screening and Early Detection: Poster Presentations - Proffered Abstracts Source Type: research

The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populations
CONCLUSIONS: Among Asians, immune checkpoint inhibitors were associated with an increased risk of major adverse cardiovascular events, particularly ischemic stroke and pulmonary embolism.PMID:36208180 | DOI:10.1093/jjco/hyac150
Source: Clinical Lung Cancer - October 8, 2022 Category: Cancer & Oncology Authors: Cho-Han Chiang Cho-Hung Chiang Kevin Sheng-Kai Ma Yuan Ping Hsia Yu-Wen Lee Han-Ru Wu Cho-Hsien Chiang Chun-Yu Peng James Cheng-Chung Wei Her-Shyong Shiah Cheng-Ming Peng Tomas G Neilan Source Type: research

"Quitting Smoking Will Benefit Your Health": The Evolution of Clinician Messaging to Encourage Tobacco Cessation.
In conclusion, instead of using loss-framed statements like "Smoking will harm your health by causing problems like lung and other cancers, heart disease, and stroke," as a general rule, physicians should use gain-framed statements like "Quitting smoking will benefit your health by preventing problems like lung and other cancers, heart disease, and stroke." Clin Cancer Res; 20(2); 1-9. ©2014 AACR. PMID: 24436474 [PubMed - as supplied by publisher]
Source: Clinical Cancer Research - January 16, 2014 Category: Cancer & Oncology Authors: Toll BA, Rojewski AM, Duncan LR, Latimer-Cheung AE, Fucito LM, Boyer JL, O'Malley SS, Salovey P, Herbst RS Tags: Clin Cancer Res Source Type: research

Impact of previous percutaneous coronary intervention on cardiovascular outcomes and mortality after lung cancer surgery: A nationwide study in Korea
ConclusionsPatients who underwent PCI before surgery for lung cancer were at a higher risk of death than those in the non ‐PCI group at one year after surgery. In addition, they showed higher short‐ and long‐term risks of revascularization than patients in the non‐PCI group. Careful long‐term management of cardiovascular risk is necessary for this population.
Source: Thoracic Cancer - July 11, 2020 Category: Cancer & Oncology Authors: Dong Woog Yoon, Dong Wook Shin, Jong Ho Cho, Jong ‐Hwan Lee, Jeong Hoon Yang, Kyungdo Han, Sang Hyun Park Tags: ORIGINAL ARTICLE Source Type: research

Cardiovascular events in cancer patients with bone metastases —A Danish population‐based cohort study of 23,113 patients
ConclusionCancer patients with bone metastases had a substantial risk of developing cardiovascular events, and these events were associated with a subsequent increased mortality. Our findings underscore the importance of continuous optimized prevention of and care for cardiovascular disease among cancer patients with bone metastases.
Source: Cancer Medicine - June 2, 2021 Category: Cancer & Oncology Authors: Peter H. Asdahl, Jens Sundb øll, Kasper Adelborg, Thomas B. Rasmussen, Anouchka M. Seesaghur, Rohini K. Hernandez, Henrik T. Sørensen, Alma B. Pedersen Tags: ORIGINAL RESEARCH Source Type: research

Impact of Comorbidities on Lung Cancer Screening Evaluation
CONCLUSION: Patient and procedure-level factors may alter the benefits of lung cancer screening. Data concerning individual risk factors and high-risk complications should therefore be incorporated into diagnostic algorithms to optimize clinical benefit and minimize harm. Further study and validation of the risk factors identified herein are warranted.PMID:35641376 | DOI:10.1016/j.cllc.2022.03.012
Source: Clinical Prostate Cancer - May 31, 2022 Category: Cancer & Oncology Authors: Eric M Robinson Benjamin Y Liu Keith Sigel Chung Yin Juan Wisnivesky Minal S Kale Source Type: research

Contraindicated Use of Bevacizumab and Toxicity in Elderly Patients With Cancer.
CONCLUSION: Our study demonstrates widespread use of bevacizumab among patients who had contraindications. Black patients were less likely to receive the drug, but those who did were more likely to have a contraindication. Efforts to understand toxicity and efficacy in populations excluded from clinical trials are needed. PMID: 24002522 [PubMed - as supplied by publisher]
Source: Clinical Lung Cancer - September 3, 2013 Category: Cancer & Oncology Authors: Hershman DL, Wright JD, Lim E, Buono DL, Tsai WY, Neugut AI Tags: J Clin Oncol Source Type: research

Midlife fitness predicts less burden of chronic disease in later life.
CONCLUSIONS: Healthy, fit, middle-aged adults developed fewer chronic conditions in later life than unfit persons and had a lesser burden of chronic disease before death. PMID: 24169299 [PubMed - in process]
Source: Clinical Lung Cancer - November 1, 2013 Category: Cancer & Oncology Authors: Rantanen T Tags: Clin J Sport Med Source Type: research

Pages: 1  2  3  4